APYX MEDICAL CORP (APYX) Forecast, Price Target & Analyst Ratings

NASDAQ:APYX • US03837C1062

Current stock price

3.605 USD
-0.15 (-4.12%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for APYX MEDICAL CORP (APYX).

Forecast Snapshot

Consensus Price Target

Price Target
$6.12
+ 69.76% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.11
Revenue Estimate
11.085M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
83.64%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$6.12
Upside
+ 69.76%
From current price of $3.61 to mean target of $6.12, Based on 11 analyst forecasts
Low
$4.04
Median
$6.12
High
$8.40

Price Target Revisions

1 Month
4.35%
3 Months
4.35%

Price Target Summary

11 Wall Street analysts provided a forecast for the next 12 months for APYX. The average price target is 6.12 USD. This implies a price increase of 69.76% is expected in the next year compared to the current price of 3.605.
The average price target has been revised upward by 4.35% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

APYX Current Analyst RatingAPYX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

APYX Historical Analyst RatingsAPYX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
83.64%
APYX was analyzed by 11 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about APYX.
In the previous month the buy percentage consensus was at a similar level.
APYX was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-11BTIGUpgrade Neutral -> Buy
2026-03-11Craig-HallumMaintains Buy -> Buy
2025-12-16Roth CapitalInitiate Buy
2025-11-12CitizensUpgrade Market Perform -> Market Outperform
2024-10-17BTIGInitiate Neutral
2024-09-16JMP SecuritiesReiterate Market Perform
2023-11-10Stephens & Co.Maintains Overweight -> Overweight
2023-08-11Piper SandlerMaintains Overweight -> Overweight
2023-07-14Stephens & Co.Initiate Overweight
2023-06-15Lake StreetMaintains Buy
2023-05-24JMP SecuritiesReiterate Market Perform -> Market Perform
2023-05-12Lake StreetMaintains Buy -> Buy
2022-08-12Piper SandlerMaintains Overweight
2022-07-19Lake StreetMaintains Buy
2022-05-20Lake StreetInitiate Buy
2021-08-13JMP SecuritiesMaintains Market Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.11
Revenue Estimate
11.085M
Revenue Q2Q
17.55%
EPS Q2Q
-8.12%
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
6.10%
EPS (1 Month)
0.00%
EPS (3 Months)
7.83%

Next Earnings Summary

APYX is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is -0.11 USD and the consensus revenue estimate is 11.09M USD.
The next earnings revenue estimate has been revised upward by 6.1% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
APYX revenue by date.APYX revenue by date.
52.349M
17.61%		48.102M
-8.11%		52.844M
9.86%		59.148M
11.93%		65.66M
11.01%		74.072M
12.81%		272.59M
268.01%		361.19M
32.50%
EBITDA
YoY % growth
APYX ebitda by date.APYX ebitda by date.
-19.259M
15.05%		-18.246M
5.26%		-5.791M
68.26%		-5.803M
-0.21%		-3.229M
44.36%		14.178M
539.09%		N/AN/A
EBIT
YoY % growth
APYX ebit by date.APYX ebit by date.
-19.951M
15.32%		-18.845M
5.54%		-6.446M
65.79%		-9.059M
-40.54%		-6.995M
22.78%		3.704M
152.95%		40.889M
1,003.91%		72.237M
76.67%
Operating Margin
APYX operating margin by date.APYX operating margin by date.
-38.11%-39.18%-12.20%-15.32%-10.65%5.00%15.00%20.00%
EPS
YoY % growth
APYX eps by date.APYX eps by date.
-0.62
7.46%		-0.67
-8.06%		-0.27
59.70%		-0.32
-18.62%		-0.28
12.98%		-0.03
89.02%		N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.11
-8.12%		-0.09
-0.30%		-0.08
-56.06%		-0.07
-125.52%		-0.08
24.53%		-0.07
20.90%		-0.06
21.57%		-0.06
17.08%
Revenue
Q2Q % growth		11.085M
17.55%		13.102M
15.20%		14.493M
12.55%		20.392M
6.41%		12.342M
11.34%		14.79M
12.88%		16.473M
13.66%		23.511M
15.30%
EBITDA
Q2Q % growth		-3.378M
-15.96%		-2.091M
9.26%		-1.235M
-210.27%		73.44K
-88.97%		-2.754M
18.47%		-1.734M
17.06%		-204K
83.48%		1.122M
1,427.78%
EBIT
Q2Q % growth		-4.068M
-33.34%		-2.842M
-10.41%		-2.047M
-146.05%		-878.22K
-8,083.82%		-3.468M
14.75%		-2.55M
10.28%		-1.122M
45.19%
100.00%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

APYX Yearly Revenue VS EstimatesAPYX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
APYX Yearly EPS VS EstimatesAPYX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -0.2 -0.4 -0.6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
23.57%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
11.71%
Revenue Next 5 Year
46.71%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
57.41%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

APYX MEDICAL CORP / APYX Forecast FAQ

What do analysts expect the price target to be for APYX MEDICAL CORP (APYX)?

11 analysts have analysed APYX and the average price target is 6.12 USD. This implies a price increase of 69.76% is expected in the next year compared to the current price of 3.605.

What is the next earnings date for APYX stock?

APYX MEDICAL CORP (APYX) will report earnings on 2026-05-07, before the market open.

What are the consensus estimates for APYX MEDICAL CORP (APYX) next earnings?

The consensus EPS estimate for the next earnings of APYX MEDICAL CORP (APYX) is -0.11 USD and the consensus revenue estimate is 11.09M USD.

Can you provide the consensus rating for APYX MEDICAL CORP stock?

The consensus rating for APYX MEDICAL CORP (APYX) is 83.6364 / 100 . This indicates that analysts generally have a positive outlook on the stock.